Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011 Jul 01; 29(19):2645-52.